The Trump administration has slashed funding for medical research, delaying some treatments and cures for health conditions ...

Chronic HBV infection remains a major global health burden, with current antiviral therapies effectively suppressing viral ...

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years ...

Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria Approval ...

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years ...

Sanofi and Regeneron's Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies showing Dupixent significantly ...

Although some outcomes showed small to medium effect sizes, these results must be interpreted cautiously given the presence ...

Lithuanian-Made Bilateral Cervical Vagus Nerve Stimulator Surpasses 100,000 Global Users as Consumer Demand for Drug-Free ...

According to Precedence Research, the global mobile pet care market size will grow from USD 809.72 million in 2025 to nearly ...

Advanced Primary Care Management codes could serve as a foundation for a more robust hybrid primary care payment model in ...

Computer Vision: This technology allows AI to ‘see’ and interpret images, like X-rays, CT scans, or MRIs. It can help ...

Margolis Center for Health Policy to the pod to discuss her recent Forefront article focused on how ACO REACH enabled ACOs to ...